Agriculture » Farming | Emerald Health Therapeutics Inc.

Emerald Health Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
97.10
108.10
31.30
253.30
937.70
1,948.40
Cost of Goods Sold (COGS) incl. D&A
91.60
85.50
436.10
916.90
1,669.40
8,484.50
Gross Income
5.60
22.50
404.90
663.60
731.70
6,536.10
SG&A Expense
94.90
150.20
3,341.30
2,434.50
8,529.00
33,626.60
EBIT
89.30
127.60
3,746.20
3,098.10
9,260.70
40,162.70
Unusual Expense
-
-
185.90
197.30
580.40
2,434.30
Non Operating Income/Expense
-
-
63.00
-
323.10
-
Interest Expense
54.90
43.90
-
39.70
-
218.60
Pretax Income
144.20
171.50
3,497.30
2,940.50
8,841.80
36,760.80
Consolidated Net Income
144.20
171.50
3,497.30
2,940.50
8,841.80
30,983.40
Net Income
144.20
171.50
3,497.30
2,940.50
8,731.80
30,576.90
Net Income After Extraordinaries
144.20
171.50
3,497.30
2,940.50
8,731.80
30,576.90
Net Income Available to Common
144.20
171.50
3,497.30
2,940.50
8,731.80
30,576.90
EPS (Basic)
0.07
0.15
0.08
0.05
0.10
0.22
Basic Shares Outstanding
2,005.40
2,005.40
46,070.80
54,264.70
88,447.60
141,443.10
EPS (Diluted)
0.07
0.09
0.08
0.05
0.10
0.22
Diluted Shares Outstanding
2,005.40
2,005.40
46,070.80
54,264.70
88,447.60
141,443.10
EBITDA
30.50
68.70
3,699.80
2,981.80
8,978.30
36,715.30
Non-Operating Interest Income
-
-
-
-
161.50
1,186.20
Minority Interest Expense
-
-
-
-
110.00
406.50

About Emerald Health Therapeutics

View Profile
Address
800 West Pender Street
Vancouver British Columbia V6C 1J8
Canada
Employees -
Website http://www.emeraldhealth.ca
Updated 07/08/2019
Emerald Health Therapeutics, Inc. is a pharmaceutical company, which engages in the development and production of medical marijuana products. Its products include dried cannabis and cannabis oil. The company was founded on Jul 31, 2007 and is headquartered in Victoria, Canada.